Negative imaging studies for primary hyperparathyroidism are unavoidable: Correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients

World Journal of Surgery

Volumn 30, Issue 5, 2006, Pages 697-704

  Mihai, Radu ^a   Gleeson, Fergus ^a   Buley, Ian D ^a   Roskell, Derek E ^a   Sadler, Gregory P ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METHYLENE BLUE; PARATHYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID TUMOR; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; SCINTIGRAPHY; SCINTILLATION CAMERA; TREATMENT OUTCOME; TUMOR LOCALIZATION; ULTRASOUND;

ADENOMA; AGED; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PREOPERATIVE CARE; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNETIUM TC 99M SESTAMIBI; ULTRASONOGRAPHY;

EID: 33646550499     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0338-9     Document Type: Article

References (37)

1. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002;17 (Suppl 2):N18-23.
2. Melton LJ III. Epidemiology of primary hyperparathyroidism. J Bone Miner Res 1991;6 (Suppl 2):S25-S30.
3. Doppman J. Reoperative parathyroid surgery: localization procedures, parathyroid surgery. Prog Surg 1986;18:117.
4. Denham DW, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg 1998;186:293-305.
5. Coackley AJ, Kettle AG, Wells CP, et al. 99Tc-sestamibi: a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-794.
6. Arbab AS, Koizumi K, Toyama K, et al. Uptake of technetium-99m- tetrofosmin, technetium-99, -MIBI and thalium-201 in tumour cell lines. J Nucl Med 1996;37:1551-1556.
7. Hetrakul N, Civelek AC, Sragg CA, et al. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery 2001;130:1011-1018.
8. O'Doherty MJ, Kettle AG, Wells P, et al. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33:313-318.
9. Kao A, Shiau YC, Tsai SC, et al. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. Eur J Nucl Med Mol Imaging 2002;29:1012-1015.
10. Sun SS, Shiau YC, Lin CC, et al. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m-MIBI parathyroid image finding. Nucl Med Biol 2001;28:929-933.
11. Taillefer R, Robidoux A, Lambert R, et al. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
12. Yen TC, Tzen KY, Lee CM, et al. Squamous cell carcinoma of the lung mimicking an ectopic mediastinal parathyroid adenoma demonstrated by Tc-99m sestamibi in a hypercalcaemic patient. Clin Nucl Med 1999;24:895-896.
13. Glaser C, Pruckmayer M, Staudenherz A, et al. Utility of technetium-99m-sestamibi to assess osseous tumour spread. J Nucl Med 1996;37:1526-1528.
14. Kos WGM, Brown MR, Balfour JF. A false-positive localization of parathyroid adenoma with technetium Tc99m-sestamibi secondary to a thyroid follicular carcinoma. Arch Surg 1996;131:216-217.
15. Scott AM, Kostakoglu L, O'Brien JP, et al. Comparison of technetium-99m-MIBI and thalium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med 1992;33:1396-1398.
16. Leslie WD, Riese KT, Mohamed C. Sestamibi retention in reactive lymph node hyperplasia: a cause of false-positive parathyroid localisation. Clin Nucl Med 2000;25:216-217.
17. Mudun A, Kocak M, Unal S, Cantez S, et al. Tc99m MIBI accumulation in remnant thymus: a cause of false-positive interpretation in parathyroid imaging. Clin Nucl Med 1995;20:379-380.
18. Campeau RJ, Reuther WL, Wayne J. False-positive Tc99m sestamibi examination for parathyroid adenoma in a case of asymmetrical salivary gland enlargement. Clin Nucl Med 1999;24:723-724.
19. Perez-Monte JE, Brown ML, Clarke MR, et al. Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium 99m-MIBI in MEN type I. J Nucl Med 1997;38:1767-1769.
20. Pattou F, Huglo D, Proye C. Radionuclide scanning in parathyroid diseases. Br J Surg 1998;85:1605-1616.
21. Leslie WD, Dupont JO, Bybel B, et al. Parathyroid (99m)Tc-sestamibi scintigraphy: dual tracer subtraction is superior to double-phase washout. Eur J Nucl Med Mol Imaging 2002;29:1566-1570.
22. Moka D, Voth E, Dietlein M, et al. Technetium 99m-MIBI-SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery 2000;128:29-35.
23. Royal RE, Delpassand ES, Shapiro SE, et al. Improving the yield of preoperative localisation: technetium Tc 99m-sestamibi imaging after thyroid suppression. Surgery 2002;132:968-975.
24. Lumachi F, Zucchetta P, Marzola MC, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 2000;143:755-760.
25. Casara D, Rubello D, Piotto A, et al. (99m)Tc-MIBI radioguided minimally invasive parathyroid surgery planned on the basis of preoperative combined (99m)Tc-pertechnetate/(99m)TC-MIBI and ultrasound imaging protocol. Eur J Nucl Med 2000;27:1300-1304.
26. Purcell GP, Dirbas FM, Jeffrey RB, et al. Parathyroid localization with high-resolution ultrasound and technetium Tc99m-sestamibi. Arch Surg 1999;134:824-830.
27. DeLellis RA. Surgical pathology of the parathyroid glands. In Randolph G, editor, Surgery of the Thyroid and Parathyroid Glands, St. Louis, MI, Elsevier, 2003;571-577.
28. Melloul M, Paz A, Koren R, Cytron S, et al. (99m)-TC-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 2001;28:209-213.
29. Carpentier A, Jeannotte S, Verreault J, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium 99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998;39(8):1441-1444.
30. Staudenherz A, Abela C, Niederle B, et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid disease. Eur J Nucl Med 1997;24:143-149.
31. Bhatnagar A, Vezza PR, Bryan JA, et al. Technetium 99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumour size on detectability. J Nucl Med 1998;39:1617-1620.
32. Ugur O, Bozkurt MF, Hamaloglu E, et al. Clinicopathologic and radiopharmacokinetic factors affecting gamma-probe-guided parathyroidectomy. Arch Surg 2004;139:1175-1179.
33. Westreich RW, Brandwein M, Mechanick JI, et al. Preoperative parathyroid localization: correlating false-negative technetium-99m-sestamibi scans with parathyroid disease. Laryngoscope 2003;113:567-572.
34. Mehta NY, Ruda JM, Kapadia S, et al. Relationship of technetium-99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue. Arch Otol Head Neck Surg 2005;131:493-498.
35. Flynn MB, Bumpous JM, Schill K, et al. Minimally invasive radioguided parathyroidectomy. J Am Coll Surg 2000;191:24-31.
36. Saint Marc O, Cogliandolo A, Pidoto RR, et al. Prospective evaluation of ultrasonography plus MIBI scintigraphy in selecting patients with primary hyperparathyroidism for unilateral neck exploration under local anaesthesia. Am J Surg 2004;187:388-393.
37. Jacobson SR, van Heerden JA, Farley DR, et al. Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe. World J Surg 2004;28:1127-1131.